Novel Therapeutic Protein
T-sphaera
Next Generation
Immunotherapy
T-sphaera Drug Conjugate
Company

Cellemedy

A biotechnology company dedicated to developing next
generation therapeutic proteins with the aim of replacing
the conventional antibody treatments.

More View
SCIENCE

SCIENCE

Cellemedy’s Innovative Technologies
for Better Human Health

Pipeline

More View

T-sphaeraᵀᴹ

More View

Multi-target Portfolio

More View
Next Generation Immunotherapy
T-sphaera Drug Conjugate
Pipeline Oncology

Notice

more +

Press Release

more +